Summary
69 / 100 · Bulios Score
What speaks for it
- Revenue grew by 15% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- Analysts expect revenue to grow by 14% this fiscal year.
What to watch
- Earnings per share swing sharply from year to year.
- 84% of profit goes to the dividend, leaving little room to raise it.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapPrice against the Bulios Fair Price
P/E against its own last 5 years
P/E against the industry (Financial - Capital Markets)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 18.3 USD for 1 USD of yearly profit. Over the last five years it was 23.7 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 10.0% a year over 5 years. Over the last 3 years it grew by 15% a year. For the next fiscal year analysts expect revenue to grow by 14%. Earnings per share grew by 11% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 30 USD
- Sales and administration 52 USD
- Taxes and other 3.9 USD
- Net profit 15 USD
Net profit, industry median (Financial - Capital Markets) 15 USD
Out of every 100 USD of revenue, 15 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 4.62%
- Paid out of profit
- 84%
- Raised in a row
- 1 year
You receive $2.60 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 6
- Hold 13
- Sell 3
Today's price within the analysts' price targets
The average target of $68.4 is 19% above today's price. 27% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
- UNITED STATES 84%
- Europe 9.8%
- Rest Of World 6.0%
UNITED STATES brings in 84% of revenue. Rest Of World grew fastest, by 6.7% a year.
Segments in detail